Antiviral treatment and prevention of seasonal influenza: A comparative review of recommendations in the European Union

Journal of Clinical Virology

Volumn 42, Issue 3, 2008, Pages 244-248

  Stephenson, Iain ^a   Clark, Tristan W ^a   Pareek, Manish ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Guidelines; Influenza; Neuraminidase inhibitors; Prevention; Treatment

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; OSELTAMIVIR; RIMANTADINE; SIALIDASE INHIBITOR; ZANAMIVIR;

ARTICLE; EUROPEAN UNION; FRANCE; GERMANY; HOUSEHOLD; HUMAN; INFLUENZA; ITALY; NETHERLANDS; POLAND; PORTUGAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; SWEDEN; UNITED KINGDOM;

ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; EUROPEAN UNION; HUMANS; INFLUENZA, HUMAN; PRACTICE GUIDELINES AS TOPIC;

EID: 45449118265     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.04.001     Document Type: Article

References (17)

1. AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: The AGREE project. Qual Saf Health Care 12 (2003) 18-23
2. Bright R.A., Medina M.J., Xu X., Perez G., Wallis T., Davis X.M., et al. Incidence of adamantine resistance among influenza A (H3N2) isolates worldwide from 1994 to 2005: a cause for concern. Lancet 366 (2005) 1175-1182
3. Ciancio B., Fernandez de la Hoz K., Kreidl P., Needham H., Nicoll A., Plata F., et al. Oseltamivir resistance in human seasonal influenza viruses (influenza A/H1N1) in EU and EFTA countries: an update. Euro Surveill 13 6 (2008). http://www.eurosurveillance.org/edition/v13n06/080207_3.asp http://www.eurosurveillance.org/edition/v13n06/080207_3.asp [accessed 18.03.08]
4. Cricelli C, Sessa A, Carosi G, Metteelli A, Crovari P, Ansaldi F. Italian Guidance on antiviral use for management and prevention of seasonal influenza. Abstract P1318. Options for the Control of Influenza VI, June 2007, Toronto, Canada.
5. Democratis J., Pareek M., and Stephenson I. The use of neuraminidase inhibitors to combat pandemic influenza. J Antimicrob Chemother 58 (2006) 911-915
6. French Writing Group. Prise en charge de la grippe en dehors d'une situation de pandemie en 2005. Medecine et Maladies Infectieuses 2005;35:S245-73.
7. Gubareva L.V., and Hayden F.G. M2 and neuraminidase inhibitors: anti-influenza activity, mechanisms of resistance and clinical effectiveness. In: Kawaoka Y. (Ed). Influenza virology: current topics (2006), Caister Press, UK 169-202
8. The Centre for Infectious Diseases Control Netherlands (CIDCN). http://www.rivm.nl/cib/infectieziekten/Influenza/Influenza.jsp [accessed 18.03.08].
9. UK Department of Health. Guidance on treatment and prevention of seasonal influenza. http://www.dh.gov.uk/en/Publichealth/Flu/Flugeneralinformation/DH_4002391 [accessed 18.03.08].
10. Prophylaxis and Treatment of Influenza. Guidelines of the College of Family Physicians of Poland. http://www.eswi.org/myUploadData/files/Flu_Guidelines_Polish_GPs.pdf [accessed 18.03.08].
11. Jefferson T., Demicheli V., Rivetti D., Jones M., Di Pietrantoni C., and Rivetti A. Antivirals for influenza in healthy adults: systematic review. Lancet 367 (2006) 303-313
12. McGeer A., Green K.A., Plevneshi A., Shigayeva A., Siddiqi N., Raboud J., et al. Antiviral therapy and outcomes of influenza requiring hospitalisation in Ontario. Can Clin Infect Dis 45 (2007) 1568-1575
13. Nichol K.L. Efficacy and clinical effectiveness of inactivated influenza virus vaccines in adults. In: Nicholson K.G., Webster R.G., and Hay A.J. (Eds). Textbook of influenza (1998), Blackwell, Oxford 358-372
14. Nicholson K.G., Wood J.M., and Zambon M. Influenza. Lancet 362 (2003) 1733-1745
15. Prata FM, Marques J.G. Antiviral therapy and prevention of influenza. Recommendations of the Portuguese SPP Paediatric Infectious Diseases Section. [Supplied by F. Hoffmann La Roche Pharmaceutical division files, September 2007].
16. Uhnoo I., Linde A., Pauksens K., Lindberg A., Eriksson M., and Norrby R. Treatment and prevention of influenza: Swedish recommendation. Scand J Infect Dis 35 (2003) 3-11
17. Wutzler P., Kossow K.D., Lode H., Ruf B.R., Scholz H., and Vogel G.E. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations. J Clin Virol 31 (2004) 84-91